Pharmabiz4d
JCR Pharma & Modalis validate initial proof of concept in a joint research programme for development of a novel gene therapy for a CNS disease
JCR Pharmaceuticals Co., Ltd., a global specialty pharmaceuticals company, and Modalis Therapeutics Corporation, a forerunner in the field of epigenetic medicine, announced that they have validated ...
Pharmabiz5d
CDSCO establishes Sub-Zonal Office in Bhubaneswar, boosting Odisha’s pharmaceutical sector
In a significant move to enhance drug regulation and monitoring in Odisha, the Central Drugs Standard Control Organisation (CDSCO) has announced the establishment of a Sub-Zonal Office in Bhubaneswar.
Pharmabiz4d
US FDA grants orphan drug designation to NMD Pharma’s NMD670 to treat patients with Charcot-Marie-tooth disease
NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with neuromuscular diseases, announces that the US Food and Drug ...
Pharmabiz4d
Claypond Capital appoints Dr Shravan Subramanyam to lead its medical technology platform
Claypond Capital, the family investment office of Manipal Group chairman Ranjan Pai, has roped in former managing director of Wipro-GE Healthcare Shravan Subramanyam to lead its medical technology ...
Pharmabiz5d
Indian healthcare sees medical networking as catalyst for quality services in remote regions
The Indian healthcare sector sees emergence of medical networking to revolutionise quality services in remote regions. This is despite the resource and infrastructural constraints leading to the ...
Pharmabiz4d
CRIUS Group adopts 100%AI-based project implementation
CRIUS Group has emerged as India’s first contract manufacturing organization (CMO) to adopt 100% AI-based project implementation. This move leverages the NutrifyGenie Integrated AI platform, marking a ...
Pharmabiz4d
Santhera enters supply and distribution agreement with Clinigen Group for Agamree to treat patients with Duchenne muscular dystrophy
Santhera Pharmaceuticals announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of Agamree (vamorolone) in countries where the product is not ...
Pharmabiz8d
Centre notifies amendments to Foreign Trade Policy 2023 to enhance stakeholder engagement
The Union ministry of commerce & industry has issued a notification introducing amendments to the Foreign Trade Policy (FTP) 2023, aimed at fostering enhanced stakeholder engagement. The notification, ...
Pharmabiz4d
Zydus enters agreement with CVS Caremark to add Zituvio, Zituvimet and Zituvimet XR to its template formulary
Zydus Lifesciences Ltd., a global innovation driven healthcare company, announced that it has entered into an agreement with CVS Caremark, a CVS Health company to add Zituvio, Zituvimet and Zituvimet ...
Pharmabiz4d
Sun Pharma inaugurates Training-Cum-Production Centre to empower women in Jammu
As a part of its CSR vision to bring about the holistic development of underserved communities in a sustainable manner, Sun Pharma, the largest pharmaceutical company in India, inaugurated a Sewing ...
Pharmabiz5d
Eton Pharma acquires Galzin, an US FDA approved treatment of ultra-rare metabolic condition of Wilson disease
Eton Pharmaceuticals, Inc, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced that it has acquired Galzin (zinc acetate). “This ...
Pharmabiz5d
MSMEs voice concern over conditional extension of revised Schedule M without providing financial support
The Bihar Pharmaceutical Manufacturers Association (BPMA) has strongly raised its voice against the decision of the Union health ministry for its conditional extension of the revised Schedule M ...